Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
29 Oct 2024
// ACCESSWIRE
16 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/932088/jaguar-health-launches-fda-approved-oral-mucositis-prescription-product-gelclair-in-the-us
11 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/925538/jaguar-health-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4
10 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/924759/magdalena-biosciences-a-joint-venture-between-jaguar-health-and-filament-health-to-present-october-16-at-bio-investor-forum
08 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/928702/jaguar-health-submits-abstract-for-first-of-kind-study-evaluating-the-impact-of-diarrhea-from-cancer-therapies-in-breast-cancer-patients-who-received-placebo-in-its-ontarget-phase-3-trial
01 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/925756/jaguar-health-reports-statistically-significant-improvement-in-breast-cancer-patients-in-its-phase-3-ontarget-trial-for-its-cancer-supportive-care-drug-crofelemer
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?